Human memory CTL response specific for influenza A virus is broad and multispecific

Citation
C. Gianfrani et al., Human memory CTL response specific for influenza A virus is broad and multispecific, HUMAN IMMUN, 61(5), 2000, pp. 438-452
Citations number
70
Categorie Soggetti
Immunology
Journal title
HUMAN IMMUNOLOGY
ISSN journal
01988859 → ACNP
Volume
61
Issue
5
Year of publication
2000
Pages
438 - 452
Database
ISI
SICI code
0198-8859(200005)61:5<438:HMCRSF>2.0.ZU;2-W
Abstract
Class I restricted cytotoxic T-lymphocyte (CTL) responses are thought to be focused against few immunodominant epitopes. In humans, an often quoted ex ample of such narrow focus is the influenza A (FLU) matrix 58-66 specific m emory CTL activity, detectable in HLA-AZ individuals as a result of natural infection. Herein, we analyzed the repertoire of memory, FLU-specific CTLs in A2 and A11 positive individuals. Eighteen A2.1 binding peptides, derive d from the FLU-Puerto Rico/8/34 (PR8) isolate, elicited CTL activity in A2. 1/Kb transgenic mice upon direct immunization. These peptides were also tes ted for their capacity to recall memory CTL responses From peripheral blood mononuclear cells (PBMC) of human A2.1 donors. Besides the known dominant M1.58 peptide, 5 new epitopes (PA.46, PA.225, PB1.413, NA.75 and M1.59) wer e identified. Similarly, eleven, All-binding, FLU-PR8 peptides, which were immunogenic in HLA-A11/Kb transgenic mice, were assayed fur induction of re call CTL responses using peripheral blood lymphocytes from a cohort of All- positive donors. Fight different peptides (NP.188, NP.342, HA.63 HA.149 HA. 450, M1.13, M1.178, and M2.70) induced memory CTL activity. Several of thes e peptides were found to be highly conserved amongst: different FLU isolate s, and also capable of binding multiple A3 and A11 supertype molecules. Fin ally, 37 HLA-B7 binding peptides were also identified. In conclusion, a pre viously unappreciated breadth of FLU-specific, memory CTL responses in huma ns was revealed. The relevance of these findings to the design of multiepit ope vaccines is discussed. Human Immunology 61, 438-452 (2000). (C) America n Society for Histocompatibility and Immunogenetics, 2000. Published by Els evier Science Inc.